In prostate cancer, decreases in PTEN protein expression, either by allelic deletion or functional loss caused by mutation and/or epigenetic modification, can lead to invasive prostate carcinoma (Trotman et al., 2003; Phin et al., 2013). Here, PTEN is linked to prostate carcinoma.